Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05611294 · ClinicalTrials.gov registry record · NA

Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction

A NA study of Myopia and Astigmatism, sponsored by Hoopes Vision.

Active
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT05611294: Active NA study of Myopia and Astigmatism, sponsored by Hoopes Vision.

NCT05611294 is a NA study of Myopia and Astigmatism that is active but no longer recruiting, run by Hoopes Vision. The registered enrollment target is 42 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05611294, a NA study of Myopia and Astigmatism, is active but no longer recruiting, sponsored by Hoopes Vision.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

This study evaluates differences in postoperative visual outcomes between patients receiving Topography-Guided LASIK in one eye and Small Incision Lenticule Extraction in the other eye.

Conditions Studied

Interventions

  • DEVICE Topography Guided LASIK Surgery
  • DEVICE Small Incision Lenticule Extraction Surgery

Study Locations (1)

Utah

  • Hoopes Vision - Draper

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2022-09-27
Est. Completion 2025-06-01
Phase NA
Hoopes Vision

2 total trials

What the registry record for NCT05611294 still lists

NCT05611294 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (84% lower).

The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Topography Guided LASIK Surgery is the first listed.

NCT05611294 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT05611294 about?

NCT05611294 is a clinical study titled "Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction". This study evaluates differences in postoperative visual outcomes between patients receiving Topography-Guided LASIK in one eye and Small Incision Lenticule Extraction in the other eye.

What is the current status of trial NCT05611294?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2022-09-27. Estimated completion is 2025-06-01.

What conditions does trial NCT05611294 study?

This clinical trial studies the following conditions: Myopia, Astigmatism.

What interventions are being tested in trial NCT05611294?

The interventions under investigation include: Topography Guided LASIK Surgery (DEVICE), Small Incision Lenticule Extraction Surgery (DEVICE).

Who is sponsoring clinical trial NCT05611294?

This trial is sponsored by Hoopes Vision, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05611294 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05611294's enrollment target sits among peer trials

42 79th of 90 higher than 12 of 90 other Myopia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05611294, the US trial registry maintained by the National Library of Medicine. NCT05611294 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.